Lung cancer outcomes have improved only marginally over the last 40 years and remain dismally poor in comparison to most other cancers: only 17.7% of women and 12.9% of men in the UK survive after ...

Lung cancer commonly spreads to organs such as the brain and bones. ... But, in rare cases, it may trigger back or abdominal pain. [8] ...

3.1 Antibody-drug conjugates 3.1.1 Rova-T. Rova-T, the first DLL3-targeting ADC developed for extensive-stage SCLC (ES-SCLC), combines a humanized monoclonal antibody with a DNA cross-linker payload ...

CHENGDU, China, June 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab ...

This marks the fifth Breakthrough Therapy Designation granted to sac-TMT by the NMPA. Sac-TMT has previously received this designation for: Locally advanced or metastatic triple-negative breast ...

Dad of four, Blair Harrison, was diagnosed with a rare type of blood cancer called multiple myeloma after likening his persistent, and extreme, back pain to “getting older.” Now, he’s sharing his ...

Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs.

Background Lung cancer is associated with poor health-related quality of life (HRQoL) and high symptom burden. This trial aimed to assess the efficacy of home-based rehabilitation versus usual care in ...

Millions of Americans are living with chronic back pain, with more than a quarter experiencing lower back pain. It is the sixth-most costly condition in the U.S. and can be incredibly debilitating ...

Higher ORR and PFS were observed in lung adenocarcinoma patients with a history of smoking. Among them, the confirmed ORR in the 0.6/1/1.5 mg/kg group (N=17) was 23.5%, and the confirmed ORR in ...

The panel discussion at the "Breathtaking Moments" event during ASCO weekend. (Johnson & Johnson) Swarner led a discussion with lung cancer survivor Maggie McCloskey, patient advocate and podcast ...